These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30344744)

  • 1. MicroRNA-206 suppresses proliferation and predicts poor prognosis of HR-HPV-positive cervical cancer cells by targeting G6PD.
    Cui J; Pan Y; Wang J; Liu Y; Wang H; Li H
    Oncol Lett; 2018 Nov; 16(5):5946-5952. PubMed ID: 30344744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
    Hu T; Chang YF; Xiao Z; Mao R; Tong J; Chen B; Liu GC; Hong Y; Chen HL; Kong SY; Huang YM; Xiyang YB; Jin H
    Oncotarget; 2016 Dec; 7(52):86103-86116. PubMed ID: 27861141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.
    Hu T; Li YS; Chen B; Chang YF; Liu GC; Hong Y; Chen HL; Xiyang YB
    Exp Biol Med (Maywood); 2015 Oct; 240(10):1287-97. PubMed ID: 25616277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-506 suppresses cervical cancer cell proliferation both in vitro and in vivo.
    Gong M; Chen C; Zhao H; Sun M; Song M
    Neoplasma; 2018 Mar; 65(3):331-338. PubMed ID: 29788724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-206 inhibits tumor metastasis of nasopharyngeal carcinoma through targeting G6PD.
    Guo Q; Ren XH; Zhao CP; Zhang BH
    J Biol Regul Homeost Agents; 2020 Apr; 34(2):. PubMed ID: 32329295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of miR-93-5p inhibits high-risk HPV-positive cervical cancer progression via targeting of BTG3.
    Li J; Chu ZP; Han H; Zhang Y; Tian F; Zhang JQ; Huang XH
    Hum Cell; 2019 Apr; 32(2):160-171. PubMed ID: 30689165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-133a, directly targeted USP39, suppresses cell proliferation and predicts prognosis of gastric cancer.
    Dong X; Su H; Jiang F; Li H; Shi G; Fan L
    Oncol Lett; 2018 Jun; 15(6):8311-8318. PubMed ID: 29805563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
    Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
    Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC.
    Qu X; Gao D; Ren Q; Jiang X; Bai J; Sheng L
    Oncol Lett; 2018 Jul; 16(1):853-860. PubMed ID: 29963155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2.
    Yang Y; Liu Y; Li G; Li L; Geng P; Song H
    Oncol Lett; 2018 Nov; 16(5):5679-5686. PubMed ID: 30344723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.
    Barajas JM; Reyes R; Guerrero MJ; Jacob ST; Motiwala T; Ghoshal K
    Sci Rep; 2018 Jun; 8(1):9105. PubMed ID: 29904144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-20a regulates cell proliferation, apoptosis and autophagy by targeting thrombospondin 2 in cervical cancer.
    Zhou Q; Dong J; Luo R; Zhou X; Wang J; Chen F
    Eur J Pharmacol; 2019 Feb; 844():102-109. PubMed ID: 30513279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
    Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD.
    Su X; Gao C; Feng X; Jiang M
    Exp Ther Med; 2020 Apr; 19(4):3081-3089. PubMed ID: 32256796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01128 expedites cervical cancer progression by regulating miR-383-5p/SFN axis.
    Hu Y; Ma Y; Liu J; Cai Y; Zhang M; Fang X
    BMC Cancer; 2019 Nov; 19(1):1157. PubMed ID: 31779593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
    Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.
    Zhang H; Yan T; Liu Z; Wang J; Lu Y; Li D; Liang W
    J Cell Biochem; 2018 Jan; 119(1):938-947. PubMed ID: 28681918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1.
    Shi C; Zhang Z
    Oncol Lett; 2017 Sep; 14(3):3809-3816. PubMed ID: 28927151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.